High risk groups are still not being vaccinated

BMJ 2005; 330 doi: https://doi.org/10.1136/bmj.330.7484.198 (Published 20 January 2005) Cite this as: BMJ 2005;330:198
  1. Adam R Winstock, area clinical director (Adam.Winstock@swsahs.nsw.gov.au)
  1. Drug Health Services, South Western Sydney Area Health Service, PO Box 39, Liverpool BC, NSW1871, Australia

    EDITOR—Aggarwal and Ranjan highlighted the global burden of hepatitis B and say that vaccination is the mainstay of prevention.1 They also describe the vaccination's lifelong efficacy and cost effectiveness. With such a clear evidence base and the recognition that certain high risk groups—such as injecting drug users—must be …

    View Full Text

    Sign in

    Log in through your institution